Zealand Pharma A/S. OverviewLatest profit margin for Zealand Pharma A/S.: -497.08% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ FollowAs of Mar 2022
Trailing 12 months ending Mar 2022
As of the most recent data (March 2022), ZEAL shows a profit margin of -497.08%. That compares with -239.68% in the prior-year period — down 107.4% year over year. That is below the Healthcare sector average of 13.76%. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, ZEAL's profit margin is now -497.08% (was -239.68%) — a 107.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Zealand Pharma A/S. is outperforming or lagging.
The Healthcare sector average profit margin is about 13.76%. Zealand Pharma A/S. is at -497.08%, which is lower that average. That is roughly 3712.4% below the sector mean. Use the comparison chart on this page to see how ZEAL stacks up against individual peers as well.
That compares with -239.68% in the prior-year period — down 107.4% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Zealand Pharma A/S. with peers to see if the move is company-specific or sector-wide.
Besides this profit margin page, Stockcircle has Zealand Pharma A/S.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently -497.08%) with ownership activity and broader fundamentals.
